Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Frankiw

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Reviews. Immunology|August 1, 2019
Alternative mRNA splicing in cancer immunotherapyLuke Frankiw, David Baltimore, Guideng Li
RNA (New York, N.Y.)|November 20, 2019
Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activityLuke Frankiw, Mati Mann, Guideng Li, et al.
Molecular Cell|January 15, 2019
BUD13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf7Luke Frankiw, Devdoot Majumdar, Christian Burns, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2024
Deciphering Membrane-Protein Interactions and High-Throughput Antigen Identification with Cell DoubletsYuqian Wang, Zhe Wang, Juan Yang, et al.
Journal for Immunotherapy of Cancer|May 8, 2023
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockadeLuke Frankiw, Arun Singh, Cole Peters, et al.
Nature Metabolism|January 30, 2023
Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemnessHongcheng Cheng, Yajing Qiu, Yue Xu, et al.
Nature Communications|May 13, 2020
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell lineYapeng Su, Melissa E Ko, Hanjun Cheng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Reviews. Immunology|August 1, 2019
Alternative mRNA splicing in cancer immunotherapyLuke Frankiw, David Baltimore, Guideng Li
RNA (New York, N.Y.)|November 20, 2019
Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activityLuke Frankiw, Mati Mann, Guideng Li, et al.
Molecular Cell|January 15, 2019
BUD13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf7Luke Frankiw, Devdoot Majumdar, Christian Burns, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2024
Deciphering Membrane-Protein Interactions and High-Throughput Antigen Identification with Cell DoubletsYuqian Wang, Zhe Wang, Juan Yang, et al.
Journal for Immunotherapy of Cancer|May 8, 2023
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockadeLuke Frankiw, Arun Singh, Cole Peters, et al.
Nature Metabolism|January 30, 2023
Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemnessHongcheng Cheng, Yajing Qiu, Yue Xu, et al.
Nature Communications|May 13, 2020
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell lineYapeng Su, Melissa E Ko, Hanjun Cheng, et al.
Pageof 1